We have located links that may give you full text access.
Substantial protective immunity conferred by a combination of Brucella abortus recombinant proteins; SodC, RibH, Ndk, L7/L12 and MDH against Brucella abortus 544 infection in BALB/c mice.
Journal of Microbiology and Biotechnology 2018 December 25
Chronic infection with intracellular Brucella abortus ( B. abortus ) in livestock remains to be a major problem worldwide. Thus, the search for an ideal vaccine is still ongoing. In this study, we evaluated the protection efficacy of a combination of B. abortus recombinant proteins; superoxide dismutase (rSodC), riboflavin synthase subunit beta (rRibH), nucleoside diphosphate kinase (rNdk), 50S ribosomal protein (rL7/L12) and malate dehydrogenase (rMDH) cloned and expressed into a pMal vector system and DH5α, respectively and further purified and applied intraperitoneally into BALB/c mice. After first immunization and two boosters, mice were infected intraperitoneally (IP) with 5×10⁴ CFU of virulent B. abortus 544. Spleens were harvested and bacterial loads were evaluated at two-week post-infection. Results revealed that this combination showed significant reduction in bacterial colonization in the spleen with a log protection unit of 1.31 which is comparable to the average protection conferred by the widely used live attenuated vaccine RB51. Cytokine analysis exhibited enhancement of cell-mediated immune response as IFN-γ is significantly elevated while IL-10 which is considered beneficial to the pathogen's survival was reduced compared to control group. Furthermore, both titers of IgG1 and IgG2a were significantly elevated at three and four-week time points from first immunization. In summary, our in vivo data revealed that vaccination with a combination of five different proteins conferred a heightened host response to Brucella infection through cell-mediated immunity which is desirable in the control of intracellular pathogens. Thus, this combination might be considered for further improvement as potential candidate vaccine against Brucella infection.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app